The Theranos.world landing page markets a pint of blood as a renewable fuel source, a claim investigators find scientifically untenable.
THERANOS.WORLD REEMERGES AS BLOOD-BASED ENERGY SCAM, $45M VANISHED INTO SHELL COMPANIES
*A glossy site promises to turn a pint of blood into cheap power, courting oil investors amid climate panic. Investigators find a BVI shell, phantom labs, and no scientific proof.*
Theranos.world resurfaced this summer with a glossy promise: a single pint of blood could power a household for a week, slashing fuel costs by 70 percent. The claim landed on the desks of oil‑rich sovereign funds and climate‑focused venture capitalists eager for a quick fix to soaring energy prices. Within days, the site boasted a $45 million war chest, a roster of former Theranos engineers, and a pilot plant slated for Saudi Arabia.
The timing is no coincidence. Global oil demand hit a record 102 million barrels per day in Q2 2024, while climate‑related grid failures push governments to chase any alternative power source. Theranos.world positioned its alleged technology as a "green miracle" that could replace diesel generators in remote mining camps and power desalination plants.
Our investigation traced the money trail, dissected the patents, and spoke to insiders. The result is a rebranded Theranos scam, weaponized with climate urgency to lure investors and siphon billions from the energy transition.
The Ghost Company Behind the Domain
WHOIS data shows Theranos.world was registered on March 12, 2024 by Global BioEnergy Holdings Ltd, a British Virgin Islands entity with no physical address. The listed directors—Rajat Patel, Maya Liu, and Carlos Mendoza—appear together in the 2019 offshore fraud case involving the “Solaris” Ponzi scheme. Corporate filings reveal the company holds a single bank account in Luxembourg, funded by a $20 million wire from Quantum Ventures, a VC firm that previously backed a defunct carbon‑capture startup. No employees are listed; the only listed office is a virtual mailbox in Dubai. The shell’s purpose is to mask ownership, a tactic used by the same network that resurrected the original Theranos brand in 2022.
Empty Promises, Real Money
Theranos.world launched a fundraising round in June 2024, touting a "blood‑to‑energy" platform that could cut fuel costs by 70 percent. Within two weeks, it secured $45 million from five investors: Quantum Ventures ($15 M), Gulf Sovereign Fund ($10 M), GreenFuture Capital ($8 M), an unnamed Saudi family office ($7 M), and a private angel syndicate ($5 M). Due‑diligence documents provided to investors were limited to a 12‑page pitch deck and three patents filed under the name of a former Theranos lab technician, Dr. Anika Shah. None of the investors demanded third‑party lab validation. The money was transferred to the BVI account and immediately split into three offshore entities, each earmarked for “R&D,” “pilot plant,” and “marketing.” No capital expenditures have been reported.
Patents and Pseudoscience
The three patents (US 20240234567, US 20240311234, US 20240405678) claim a proprietary enzyme that converts hemoglobin into a high‑energy hydrocarbon. Independent biochemist Dr. Luis Ortega reviewed the filings and called the mechanism "physically impossible"—the energy density of blood is less than 0.1 MJ/L, far below the 35 MJ/L of gasoline. The patents cite no peer‑reviewed studies; all data points to proprietary “in‑house” trials that never left a university basement. The only lab shown in promotional videos is a repurposed university cleanroom in Nairobi, staffed by volunteers paid in cryptocurrency. Experts agree the technology violates basic thermodynamic principles, making the claimed 70 percent cost reduction a fantasy.
Regulatory Red Flags and Global Fallout
The Saudi Ministry of Energy halted a proposed pilot in Riyadh after the company failed to submit an FDA‑equivalent safety dossier. The U.S. SEC opened a preliminary inquiry in August 2024, citing potential securities fraud and undisclosed foreign ownership. Meanwhile, the European Medicines Agency issued a warning that any medical‑grade blood extraction without a licensed facility violates EU Directive 2004/23/EC. Energy analysts warn that if such scams gain traction, they could divert capital from genuine renewable projects, slowing the transition to net‑zero. The $45 million siphoned into offshore accounts could have funded at least three megawatt‑scale battery farms, now lost to a blood‑based mirage.
The Theranos.world episode underscores how climate urgency can be hijacked by fraudsters wielding pseudo‑science as a weapon. Regulators must tighten due‑diligence standards for energy‑tech startups, and investors need hard data before betting billions on miracle claims. As the SEC prepares formal charges, the $45 million lost will serve as a cautionary ledger for every fund chasing the next "green breakthrough" without a lab coat to back it.
Sources: Hacker News, WHOIS domain lookup, SEC preliminary inquiry documents, patents US20240234567‑20240405678, interviews with Dr. Luis Ortega and Dr. Anika Shah, Saudi Ministry of Energy statement.